What is the etiology, clinical features, diagnosis, and management of parapneumonic effusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parapneumonic Effusion: Etiology, Clinical Features, Diagnosis, and Management

Etiology

Parapneumonic effusions occur most frequently with bacterial pneumonia, affecting 2-12% of children with community-acquired pneumonia and up to 50% of cases caused by typical bacteria including S. pneumoniae, S. pyogenes, and S. aureus. 1

  • In previously well children, effusions are usually secondary to acute bacterial pneumonia, with S. pneumoniae being the predominant pathogen 1
  • M. pneumoniae causes effusions in up to 20% of cases, and viral pneumonias in 10%, though these rarely require intervention 1
  • The pathophysiology follows three progressive stages: exudative (clear fluid, low WBC, normal glucose), fibropurulent (fibrin deposition with septation/loculation), and organizational (pleural peel formation) 2, 3

Clinical Features

Key clinical features include prolonged fever despite antibiotic therapy, chest pain, and abdominal pain—all strongly associated with parapneumonic effusion. 1, 2

  • Physical examination reveals dullness to percussion, diminished breath sounds, and altered quality of breath sounds/transmitted speech over the effusion 1
  • Patients are typically more unwell than those with simple pneumonia, presenting with persistent high fever despite appropriate antibiotics 4
  • Pleuritic chest pain is common, and patients may lie on the affected side to splint the hemithorax 4
  • Unilateral decreased chest expansion and possibly scoliosis may be observed 4

Diagnosis

Chest radiography with lateral decubitus views should confirm the presence of pleural fluid; if uncertainty exists, chest ultrasound is preferred over CT due to lack of ionizing radiation. 1, 2

Imaging Approach:

  • Look for obliteration of the costophrenic angle or meniscus sign of fluid ascending the lateral chest wall on chest radiograph 4
  • Ultrasound must be used to confirm pleural fluid presence, assess for loculations, and guide any thoracentesis or drain placement 2, 4
  • If patient remains febrile or unwell 48 hours after admission, parapneumonic effusion must be actively excluded through repeat chest radiography 4

Pleural Fluid Analysis:

  • Gram stain and bacterial culture should be performed whenever pleural fluid is obtained (positive in up to 49% of cases, though most report <25%) 1
  • All non-purulent, possibly infected effusions require pleural fluid pH assessment 2
  • PCR and antigen testing increase pathogen detection (42-80% of samples) and are useful for management 1
  • WBC count with differential helps differentiate bacterial from mycobacterial, fungal, or malignancy etiologies 1

Classification (British Thoracic Society):

  • Simple parapneumonic effusion: pH >7.2, LDH <1000 IU/L, glucose >2.2 mmol/L, negative culture—resolves with antibiotics alone 2
  • Complicated parapneumonic effusion: pH <7.2, LDH >1000 IU/L, may have positive culture—requires chest tube drainage 2
  • Empyema: frank pus, WBC >50,000/μL, may have positive culture—requires chest tube drainage 2

Management

The size of the effusion and the child's degree of respiratory compromise are the two most important factors determining management. 1

Size-Based Algorithm:

Small effusions (<10mm rim on lateral decubitus or <1/4 hemithorax):

  • Treat with antibiotics alone without drainage 1, 4
  • All small effusions in one series recovered uneventfully without requiring drainage 1

Moderate effusions (1/4 to 1/2 hemithorax):

  • In absence of mediastinal shift, only 27% required drainage 1
  • Majority can be managed successfully without pleural drainage 1
  • Monitor closely; only 1 child required readmission for drainage in one series 1

Large effusions (>1/2 hemithorax):

  • 66% ultimately required pleural drainage 1
  • Drain any effusion meeting at least one criterion: loculations present, pH <7.2, glucose <60 mg/dl, positive Gram stain/culture, or purulent appearance 2, 4

Drainage Methods:

  • Frankly purulent or turbid/cloudy pleural fluid on sampling mandates prompt chest tube drainage 2
  • Image-guided catheter placement is safe and highly effective in select patients 5
  • Intrapleural fibrinolytic agents remain controversial but may have a role in early complicated, loculated effusions 6, 7
  • Surgical options (VATS or thoracotomy) are reserved for failed medical management 5, 6

Antibiotic Therapy:

  • Complicated infections with effusions/empyema may require therapy for >10 days 1
  • Some experts treat appropriately drained effusion 7-10 days after fever resolution, others recommend up to 4-6 weeks 1
  • Clinical improvement should occur within 48-72 hours; if not, further investigation is required 1

Follow-Up:

  • Children should be followed until complete recovery and chest radiograph returns to near normal 1
  • Prognosis in children is usually very good with complete recovery and normal lung function 4
  • Secondary scoliosis is common but transient; no specific treatment required but resolution must be confirmed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Parapneumonic Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pneumonia and empyema: causal, casual or unknown.

Journal of thoracic disease, 2015

Guideline

Pleural Effusions After Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of parapneumonic effusions.

Seminars in respiratory and critical care medicine, 2008

Research

Parapneumonic pleural effusion and empyema.

Respiration; international review of thoracic diseases, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.